User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Metastatic cutaneous apocrine adenocarcinoma successfully treated with systemic anti‐androgen therapy—A case report

Primary tabs

download
  • Open access
  • PDF
  • 860.77 K
Collette, Fanny [UCL] Hamoir, Marc Van Eeckhout, Pascal D’Abadie, Philippe Duprez, Thierry Schmitz, Sandra [UCL] Machiels, Jean‐Pascal [UCL]

Primary cutaneous apocrine adenocarcinoma (PCAC) is an extremely rare neoplasm involving the sweat glands. Due to a lack of cases, there is no consensus for the systemic treatment of locally advanced or metastatic PCAC. Anti-androgen therapy may have activity in inoperable or metastatic PCAC with high androgen receptor (AR) expression.

Document type Article de périodique (Journal article) – Article de recherche
Access type Accès libre
Publication date 2020
Language Anglais
Journal information "Clinical Case Reports" - Vol. 8, no. 12, p. 3472-3478 (2020)
Peer reviewed yes
Publisher Wiley
issn 2050-0904
e-issn 2050-0904
Publication status Publié
Affiliations UCL - SSS/IREC/MONT - Pôle Mont Godinne
UCL - (MGD) Service d'oncologie médicale
Keywords androgen receptor ; anti-androgen therapy ; metastatic cancer ; Primary cutaneous apocrine adenocarcinoma ; sweat glands
Links
Bibliographic reference Collette, Fanny ; Hamoir, Marc ; Van Eeckhout, Pascal ; D’Abadie, Philippe ; Duprez, Thierry ; et. al. Metastatic cutaneous apocrine adenocarcinoma successfully treated with systemic anti‐androgen therapy—A case report. In: Clinical Case Reports, Vol. 8, no. 12, p. 3472-3478 (2020)
Permanent URL http://hdl.handle.net/2078.1/239250